a year ago
LBPH
AnalystsAlethia YoungAlethia Young's Stock Forecasts
AnalystsAlethia Young
Analyst Ranking
Top 1%
#34 out of 4565 analysts
Average Return
+43.91%
Win Rate
55%57 out of 104
Risk vs Reward
Poor
Good
Alethia Young's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pacific Biosciences Of California IncPACB | +781.46% | $3.56 | $31.38 | 2020-03-09 - 2021-03-09 | Strong Buy |
Curis IncCRIS | +479.03% | $24.80 | $143.60 | 2020-07-17 - 2021-07-16 | Strong Buy |
Anaptysbio IncANAB | +260.34% | $23.85 | $85.94 | 2017-08-25 - 2018-08-24 | Buy |
Alx Oncology Holdings IncALXO | +244.29% | $4.90 | $16.87 | 2023-08-14 - 2024-04-25 | Strong Buy |
Alx Oncology Holdings IncALXO | +239.44% | $4.97 | $16.87 | 2023-09-07 - 2024-04-25 | Strong Buy |
Alethia Young Analyst Color
Get additional color on Alethia Young's coverage of popular stocks
Alethia Young's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 7 | Hold | $850.00 | -4.57% | Maintains | 6 months ago |
Arcus Biosciences IncRCUS | 4 | Strong Buy | $46.00 | +212.29% | Reiterates | 7 months ago |
Alx Oncology Holdings IncALXO | 6 | Strong Buy | $18.00 | +6.70% | Reiterates | 7 months ago |
Curis IncCRIS | 3 | Strong Buy | $60.00 | +313.22% | Reiterates | 8 months ago |
Longboard Pharmaceuticals IncLBPH | 5 | Strong Buy | $16.00 | -16.88% | Reiterates | 8 months ago |
Eledon Pharmaceuticals IncELDN | 2 | Strong Buy | $9.00 | +345.54% | Reiterates | 8 months ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Strong Buy | $47.00 | +114.91% | Maintains | 9 months ago |
Theseus Pharmaceuticals IncTHRX | 2 | Strong Buy | $7.00 | +72.41% | Maintains | 9 months ago |
Verastem IncVSTM | 2 | Strong Buy | $34.00 | +268.96% | Reiterates | 10 months ago |
Neximmune IncNEXI | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Arena Pharmaceuticals IncARNA | 5 | Hold | $100.00 | N/A | Downgrades | 2 years ago |
Biogen IncBIIB | 4 | Hold | $327.00 | N/A | Maintains | 3 years ago |
Adverum Biotechnologies IncADVM | 4 | Hold | $30.00 | N/A | Downgrades | 3 years ago |
Rapt Therapeutics IncRAPT | 1 | Strong Buy | $71.00 | N/A | Maintains | 3 years ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $281.00 | N/A | Maintains | 3 years ago |
Provention Bio IncPRVB | 2 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 3 years ago |
Fate Therapeutics IncFATE | 1 | Strong Buy | $98.00 | N/A | Maintains | 3 years ago |
Amgen IncAMGN | 6 | Strong Buy | $295.00 | N/A | Maintains | 3 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Gilead Sciences IncGILD | 2 | Strong Buy | $84.00 | N/A | Maintains | 4 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $35.00 | N/A | Maintains | 4 years ago |
Marinus Pharmaceuticals IncMRNS | 3 | Strong Buy | $24.00 | N/A | Reiterates | 4 years ago |
Stemline Therapeutics IncSTML | 2 | Hold | $12.50 | N/A | Downgrades | 4 years ago |
Ascendis Pharma AASND | 5 | Strong Buy | $201.00 | N/A | Reiterates | 4 years ago |
Ptc Therapeutics IncPTCT | 3 | Strong Buy | $85.00 | N/A | Reiterates | 4 years ago |
Pacific Biosciences Of California IncPACB | 1 | Strong Buy | $5.00 | N/A | Assumes | 4 years ago |
Aurinia Pharmaceuticals IncAUPH | 1 | Strong Buy | $32.00 | N/A | Maintains | 4 years ago |
Sarepta Therapeutics IncSRPT | 6 | Strong Buy | $217.00 | N/A | Reiterates | 4 years ago |
Agios Pharmaceuticals IncAGIO | 4 | Strong Buy | $70.00 | N/A | Reiterates | 4 years ago |
Incyte CorpINCY | 2 | Hold | $65.00 | N/A | Maintains | 4 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | $4.00 | N/A | Downgrades | 4 years ago |
Ra Pharmaceuticals IncRARX | 3 | Buy | $17.00 | N/A | Maintains | 6 years ago |
Anaptysbio IncANAB | 2 | Buy | $104.00 | N/A | Initiates Coverage On | 6 years ago |
Alexion Pharmaceuticals IncALXN | 3 | Buy | $154.00 | N/A | Maintains | 6 years ago |
Tesaro IncTSRO | 3 | Buy | $128.00 | N/A | Maintains | 6 years ago |
Mesoblast LtdMESO | 3 | Sell | N/A | N/A | Downgrades | 6 years ago |
Alnylam Pharmaceuticals IncALNY | 3 | Buy | $154.00 | N/A | Maintains | 6 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $116.00 | N/A | Maintains | 6 years ago |
Celgene CorpCELG | 1 | Buy | $129.00 | N/A | Maintains | 6 years ago |
Cencora IncCOR | 1 | Buy | $112.00 | N/A | Maintains | 6 years ago |
Puma Biotechnology IncPBYI | 4 | Buy | $106.00 | N/A | Maintains | 6 years ago |
Bioverativ IncBIVV | 3 | Hold | $105.00 | N/A | Maintains | 6 years ago |
Acceleron Pharma IncXLRN | 1 | Buy | $51.00 | N/A | Maintains | 6 years ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $28.00 | N/A | Maintains | 6 years ago |
Darden Restaurants IncDRI | 1 | Hold | $82.00 | N/A | Maintains | 7 years ago |
United Therapeutics CorpUTHR | 1 | Sell | N/A | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.